0000899243-22-026460.txt : 20220721
0000899243-22-026460.hdr.sgml : 20220721
20220721152157
ACCESSION NUMBER: 0000899243-22-026460
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220718
FILED AS OF DATE: 20220721
DATE AS OF CHANGE: 20220721
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WIINBERG ULF
CENTRAL INDEX KEY: 0001187314
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40908
FILM NUMBER: 221096966
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MiNK Therapeutics, Inc.
CENTRAL INDEX KEY: 0001840229
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 149 FIFTH AVENUE
STREET 2: SUITE 500
CITY: NEW YORK
STATE: NY
ZIP: 10010
BUSINESS PHONE: 212-994-8250
MAIL ADDRESS:
STREET 1: 149 FIFTH AVENUE
STREET 2: SUITE 500
CITY: NEW YORK
STATE: NY
ZIP: 10010
FORMER COMPANY:
FORMER CONFORMED NAME: AgenTus Therapeutics, Inc.
DATE OF NAME CHANGE: 20210112
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-07-18
0
0001840229
MiNK Therapeutics, Inc.
INKT
0001187314
WIINBERG ULF
149 FIFTH AVENUE, SUITE 500
NEW YORK
NY
10010
1
0
0
0
Common Stock
2022-07-18
4
P
0
3339
1.329
A
281639
D
Common Stock
2022-07-19
4
P
0
16661
1.393
A
298300
D
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $1.31 - $1.44. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $1.37 - $1.51. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
By: /s/ Christine Klaskin, Attorney-in-Fact
2022-07-21